Johnston, Brian D.
Thuras, Paul
Porter, Stephen B.
Clabots, Connie
Johnson, James R. http://orcid.org/0000-0002-9588-5045
Funding for this research was provided by:
achaogen/cipla
Article History
Received: 26 March 2021
Accepted: 15 April 2021
First Online: 23 April 2021
Declarations
: Ethics approval (include appropriate approvals or waivers): The study was approved by the MVAMC Institutional Review Board.
: Not applicable.
: Not applicable.
: James R. Johnson has had grants and/or consultancies with Allergan/Actavis, Cipla/Achaogen, Janssen/Crucell, Melinta/The Medicines Company, Merck, Shionogi, Syntiron, and Tetraphase. The other authors report no financial conflicts of interest.
: The opinions expressed here are strictly those of the authors and do not necessarily represent those of the Department of Veteran Affairs or the authors' institutions.